Chalcone Scaffold in Anticancer Armamentarium: A Molecular Insight

Journal of Toxicology

Volumn 2016, Issue , 2016, Pages

  Das, Manik ^a   Manna, Kuntal ^a  

^a TRIPURA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN H; CHALCONE;

ADENOCARCINOMA CELL LINE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BLADDER CANCER CELL LINE; BRAIN TUMOR CELL LINE; BREAST CANCER CELL LINE; COLON CANCER; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; LEUKEMIA CELL LINE; LUNG CANCER CELL LINE; MULTIPLE CANCER; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; REVIEW; UTERINE CERVIX CANCER;

EID: 84955565287     PISSN: 16878191     EISSN: 16878205     Source Type: Journal    
DOI: 10.1155/2016/7651047     Document Type: Review

References (48)

1. American Cancer Society, Global Cancer Facts & Figures, American Cancer Society, Atlanta, Ga, USA, 2nd edition, 2011.
2. M. R. Alison, "Cancer, " Encyclopedia of life sciences, Nature Publishing Group, 2011, http://www.els.net.
3. D. N. Dhar, The Chemistry of Chalcones and Related Compounds, John Wiley & Sons, New York, NY, USA, 1981.
4. N. K. Sahu, S. S. Balbhadra, J. Choudhary, and D. V. Kohli, "Exploring pharmacological signifcance of chalcone scafold: a review, " Current Medicinal Chemistry, vol. 19, no. 2, pp. 209-225, 2012.
5. B. V. Babu, N. K. Konduru, W. Nakanishi, S. Hayashi, N. Ahmed, and P. M. Mitrasinovic, "Experimental and theoretical advances in functional understanding of favonoids as anti-tumor agents, " Anti-Cancer Agents in Medicinal Chemistry, vol. 13, no. 2, pp. 307-332, 2013.
6. A. Boumendjel, X. Ronot, and J. Boutonnat, "Chalcones derivatives acting as cell cycle blockers: potential anti-cancer drugs?" Current Drug Targets, vol. 10, no. 4, pp. 363-371, 2009.
7. D. I. Batovska and I. T. Todorova, "Trends in utilization of the pharmacological potential of chalcones, " Current Clinical Pharmacology, vol. 5, no. 1, pp. 1-29, 2010.
8. J. R. Dimmock, D. W. Elias, M. A. Beazely, and N. M. Kandepu, "Bioactivities of chalcones, " Current Medicinal Chemistry, vol. 6, no. 12, pp. 1125-1149, 1999.
9. Z. Rozmer and P. Perjési, "Naturally occurring chalcones and their biological activities, " Phytochemistry Reviews, 2014.
10. N. Abu, W. Y. Ho, S. K. Yeap et al., "The favokawains: uprising medicinal chalcones, " Cancer Cell International, vol. 13, no. 1, article 102, pp. 2-7, 2013.
11. E.-H. Zhang, R.-F. Wang, S.-Z. Guo, and B. Liu, "An update on antitumor activity of naturally occurring chalcones, " Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 815621, 22 pages, 2013.
12. H. Lodish, A. Berk, S. L. Zipursky, P. Matsudaira, D. Baltimore, and J. Darnell, Molecular Cell Biology, W. H. Freeman, New York, NY, USA, 4th edition, 2000.
13. K. H. Vousden and D. P. Lane, "p53 in health and disease, " Nature Reviews Molecular Cell Biology, vol. 8, no. 4, pp. 275-283, 2007.
14. E. Winter, L. D. Chiaradia, C. A. S. de Cordova, R. J. Nunes, R. A. Yunes, and T. B. Creczynski-Pasa, "Naphthylchalcones induce apoptosis and caspase activation in a leukemia cell line: the relationship between mitochondrial damage, oxidative stress, and cell death, " Bioorganic and Medicinal Chemistry, vol. 18, no. 22, pp. 8026-8034, 2010.
15. E. Winter, L. D. Chiaradia, A. H. Silva, R. J. Nunes, R. A. Yunes, and T. B. Creczynski-Pasa, "Involvement of extrinsic and intrinsic apoptotic pathways together with endoplasmic reticulum stress in cell death induced by naphthylchalcones in a leukemic cell line: advantages of multi-target action, " To x i c o l o g y in Vitro, vol. 28, no. 5, pp. 769-777, 2014.
16. A. Costa, L. D. Chiaradia-Delatorre, L. dos Santos Bubniak et al., "Apoptotic efect of synthetic 2, 4, 5-trimethoxychalcones in human K562 and Jurkat leukemia cells, " Medicinal Chemistry Research, vol. 23, no. 10, pp. 4301-4319, 2014.
17. C. Seidel, M. Schnekenburger, C. Zwergel et al., "Novel inhibitors of human histone deacetylases: design, synthesis and bioactivity of 3-alkenoylcoumarines, " Bioorganic & Medicinal Chemistry Letters, vol. 24, no. 16, pp. 3797-3801, 2014.
18. B. Orlikova, J. C. J. M. D. S. Menezes, S. Ji, S. P. Kamat, J. A. S. Cavaleiro, and M. Diederich, "Methylenedioxy favonoids: assessment of cytotoxic and anti-cancer potential in human leukemia cells, " European Journal of Medicinal Chemistry, vol. 84, pp. 173-180, 2014.
19. J. M. Lee, M. S. Lee, D. Koh, Y. H. Lee, Y. Lim, and S. Y. Shin, "A new synthetic 2-hydroxy-2, 4, 6-trimethoxy-5, 6-naphtho-chalcone induces G2/M cell cycle arrest and apoptosis by disrupting the microtubular network of human colon cancer cells, " Cancer Letters, vol. 354, no. 2, pp. 348-354, 2014.
20. C. W. Mai, M. Yaeghoobi, N. Abd-Rahman, Y. B. Kang, and M. R. Pichika, "Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins, " European Journal of Medicinal Chemistry, vol. 77, pp. 378-387, 2014.
21. V. Markovíc, N. Debeljak, T. Stanojkovíc et al., "Anthraquinone-chalcone hybrids: synthesis, preliminary antiproliferative evaluation and DNA-interaction studies, " European Journal of Medicinal Chemistry, vol. 89, pp. 401-410, 2015.
22. N. Singh, J. Sarkar, K. V. Sashidhara, S. Ali, and S. Sinha, "Anti-tumour activity of a novel coumarin-chalcone hybrid is mediated through intrinsic apoptotic pathway by inducing PUMA and altering Bax/Bcl-2 ratio, " Apoptosis, vol. 19, no. 6, pp. 1017-1028, 2014.
23. M. Wan, L. Xu, L. Hua et al., "Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents, " Bioorganic Chemistry, vol. 54, pp. 38-43, 2014.
24. B. Kolundz?ija, V. Marković, T. Stanojković et al., "Novel anthra-quinone based chalcone analogues containing an imine fragment: synthesis, cytotoxicity and anti-angiogenic activity, " Bio-organic & Medicinal Chemistry Letters, vol. 24, no. 1, pp. 65-71, 2014.
25. C.-H. Tseng, Y.-L. Chen, C.-Y. Hsu et al., "Synthesis and antipro-liferative evaluation of 3-phenylquinolinylchalcone derivatives against non-small cell lung cancers and breast cancers, " European Journal of Medicinal Chemistry, vol. 59, pp. 274-282, 2013.
26. D. Kumar, N. Maruthi Kumar, M. P. Tantak, M. Ogura, E. Kusaka, and T. Ito, "Synthesis and identifcation of?-cyano bis(indolyl)chalcones as novel anticancer agents, " Bioorganic & Medicinal Chemistry Letters, vol. 24, no. 22, pp. 5170-5174, 2014.
27. W. He, Y. Jiang, X. Zhang, Y. Zhang, H. Ji, and N. Zhang, "Anti-cancer cardamonin analogs suppress the activation of NF-kappaB pathway in lung cancer cells, " Molecular and Cellular Biochemistry, vol. 389, no. 1-2, pp. 25-33, 2014.
28. S. S. Chauhan, A. K. Singh, S. Meena et al., "Synthesis of novel?-carboline based chalcones with high cytotoxic activity against breast cancer cells, " Bioorganic & Medicinal Chemistry Letters, vol. 24, no. 13, pp. 2820-2824, 2014.
29. C. L. Ye, X. G. Liu, Q. Huang, and X. L. Zhao, "Induction of apoptosis in human hepatoma SMMC-7721 cells using 2, 4-dihydroxy-6-methoxy-3, 5-dimethylchalcone, a chalcone from buds of Cleistocalyx operculatus, " Food Science and Biotechnology, vol. 22, no. 5, pp. 1421-1427, 2013.
30. L. Wang, G. Chen, X. Lu et al., "Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: synthesis, anti-invasive and anti-angiogenic properties, " European Journal of Medicinal Chemistry, vol. 89, pp. 88-97, 2015.
31. K.-H. Shen, J.-K. Chang, Y.-L. Hsu, and P.-L. Kuo, "Chalcone arrests cell cycle progression and induces apoptosis through induction of mitochondrial pathway and inhibition of nuclear factor kappa B signalling in human bladder cancer cells, " Basic & Clinical Pharmacology & Toxicology, vol. 101, no. 4, pp. 254-261, 2007.
32. M. R. El Sayed Aly, H. H. Abd El Razek Fodah, and S. Y. Saleh, "Antiobesity, antioxidant and cytotoxicity activities of newly synthesized chalcone derivatives and their metal complexes, " European Journal of Medicinal Chemistry, vol. 76, pp. 517-530, 2014.
33. M. Abdel-Aziz, S.-E. Park, G. E.-D. A. A. Abuo-Rahma, M. A. Sayed, and Y. Kwon, "Novel N-4-piperazinyl-ciprofoxacin-chalcone hybrids: synthesis, physicochemical properties, anti-cancer and topoisomerase I and II inhibitory activity, " European Journal of Medicinal Chemistry, vol. 69, pp. 427-438, 2013.
34. G. Wang, F. Peng, D. Cao et al., "Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors, " Bioorganic & Medicinal Chemistry, vol. 21, no. 21, pp. 6844-6854, 2013.
35. G. Wang, C. Li, L. He et al., "Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents, " Bioorganic & Medicinal Chemistry, vol. 22, no. 7, pp. 2060-2079, 2014.
36. J. Zhang, F.-J. Ji, Y. Gu, X.-Y. Zhang, and S.-X. Qiao, "Chal-cones derivatives as potent Cell division cycle 25B phosphatase inhibitors, " Pharmacological Reports, vol. 66, no. 3, pp. 515-519, 2014.
37. U. Sankappa Rai, A. M. Isloor, P. Shetty, K. S. R. Pai, and H. K. Fun, "Synthesis and in vitro biological evaluation of new pyrazole chalcones and heterocyclic diamides as potential anti-cancer agents, " Arabian Journal of Chemistry, vol. 8, no. 3, pp. 317-321, 2015.
38. Y.-P. Li, Y.-C. Yang, Y.-K. Li et al., "Prenylated chalcones from Desmodium renifolium, " Phytochemistry Letters, vol. 9, no. 1, pp. 41-45, 2014.
39. A. H. Banday, S. M. M. Akram, and S. A. Shameem, "Benzy-lidine pregnenolones and their oximes as potential anticancer agents: synthesis and biological evaluation, " Steroids, vol. 84, pp. 64-69, 2014.
40. R. Pingaew, A. Saekee, P. Mandi et al., "Synthesis, biological evaluation and molecular docking of novel chalcone-coumarin hybrids as anticancer and antimalarial agents, " European Journal of Medicinal Chemistry, vol. 85, pp. 65-76, 2014.
41. D. Cao, X. Han, G. Wang et al., "Synthesis and biological evaluation of novel pyranochalcone derivatives as a new class of microtubule stabilizing agents, " European Journal of Medicinal Chemistry, vol. 62, pp. 579-589, 2013.
42. H. Wei, X. Zhang, G. Wu et al., "Chalcone derivatives from the fern Cyclosorus parasiticus and their anti-proliferative activity, " Food and Chemical Toxicology, vol. 60, pp. 147-152, 2013.
43. Á. Sánchez-Picó, A. J. León-González, C. Martin-Cordero, and R. R. Daga, "Screening for natural anticancer agents using a fssion yeast bioassay, " Phytochemistry Letters, vol. 8, pp. 184-189, 2014.
44. N. Raghav and S. Garg, "SAR studies of o-hydroxychalcones and their cyclized analogs and study them as novel inhibitors of cathepsin B and cathepsin H, " European Journal of Pharmaceutical Sciences, vol. 60, pp. 55-63, 2014.
45. Y. Ahn, S. Oh, S. J. Lee et al., "Synthesis of diethylamino-curcumin mimics with substituted triazolyl groups and their sensitization efect of TRAIL against brain cancer cells, " Bioor-ganic and Medicinal Chemistry Letters, vol. 24, no. 15, pp. 3346-3350, 2014.
46. V. Kuete, A. H. L. Nkuete, A. T. Mbaveng et al., "Cytotoxicity and modes of action of 4-hydroxy-2, 6-dimethoxychalcone and other favonoids toward drug-sensitive and multidrug-resistant cancer cell lines, " Phytomedicine, vol. 21, no. 12, pp. 1651-1657, 2014.
47. I. S. Aljancić, I. Vucković, M. Jadranin et al., "Two structurally distinct chalcone dimers from Helichrysum zivojinii and their activities in cancer cell lines, " Phytochemistry, vol. 98, pp. 190-196, 2014.
48. S. Y. Shin, H. Jung, S. Ahn et al., "Polyphenols bearing cinna-maldehyde scafold showing cell growth inhibitory efects on the cisplatin-resistant A2780/Cis ovarian cancer cells, " Bioor-ganic & Medicinal Chemistry, vol. 22, no. 6, pp. 1809-1820, 2014.